Jiangsu Hengrui Pharmaceuticals Hits Day High with 8.75% Surge

Jiangsu Hengrui Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.75% on June 29, 2026. The stock reached an intraday high of CNY 53.31, marking a notable achievement in its trading activity for the day. In terms of performance metrics, Jiangsu Hengrui has outperformed the China Shanghai Composite index, which recorded a modest increase of 1.16% on the same day. Over the past week, the stock has shown a robust gain of 7.23%, contrasting with a decline of 2.14% in the broader index. Despite a year-to-date decline of 11.15%, the company has demonstrated resilience with a 1.89% increase over the past year, while its profits have risen by 32.1%. The stock's current price reflects a high dividend yield of 0.44%, and it maintains a return on equity of 12.33%. With a market capitalization of CNY 292,524 million, Jiangsu Hengrui continues to be a significant player in the pharmaceuticals and biotechnology sector.